Sen. Jerry Moran (center) and Richard Hodes (right), director with the National Institute of Aging, spoke Monday with clinical trials patient John Palmer of Overland Park at the KU Clinical Research Center in Fairway.
Sen. Jerry Moran (center) and Richard Hodes (right), director with the National Institute of Aging, spoke Monday with clinical trials patient John Palmer of Overland Park at the KU Clinical Research Center in Fairway. David Eulitt deulitt@kcstar.com
Sen. Jerry Moran (center) and Richard Hodes (right), director with the National Institute of Aging, spoke Monday with clinical trials patient John Palmer of Overland Park at the KU Clinical Research Center in Fairway. David Eulitt deulitt@kcstar.com

U.S. research official points to progress against Alzheimer’s in visit to KU Med Center

February 15, 2016 08:53 PM

More Videos

  • First treatment that genetically modifies patients’ cells to destroy cancer approved by FDA

    T-cells are one of immune system’s key soldiers, targeting infected or abnormal cells but cancer can block those defenses. Now scientists are genetically modifying patients own cells to make them smarter and tougher at seeking out and destroying cancer. One version is called CAR-T cell therapy, T-cells customized to zero in on a patients specific kind of cancer.